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cytoplasmic portion of the L-selectin protein, pointingIL-6 trans-Signaling:
to an intracellular signaling mechanism. Surprisingly,The Heat Is On the authors demonstrate that L-selectin activation is
mediated through stimulation of the cytokine receptor
gp130 by interleukin-6 (IL-6) in combination with its solu-
ble (sIL-6R) rather than its membrane-bound receptor.
The molecular consequence of the fever response has Thus IL-6-driven immune responses mediated by the
been illuminated by a recent study showing that a soluble IL-6R emerge as a molecular consequence of
temperature shift to 40C resulted in increased leuko- the febrile reaction in the human body.
cyte adhesion to tissue sections, which was mediated gp130 is the common receptor subunit for the cyto-
by L-selectin activation in lymphocytes. This L-selectin kines IL-6, IL-11, IL-27, CNTF, CT-1, CLC, LIF, and OSM.
activation during heat responses was dependent on On target cells, IL-6 first binds to the membrane-bound
IL-6 trans-signaling via the soluble IL-6R. IL-6R. The complex of IL-6 and membrane-bound IL-6R
associates with gp130, inducing gp130 dimerization and
Febrile viral infections such as influenza cause signifi- the initiation of intracellular signaling. gp130 is ex-
cant morbidity, mortality, and economic disruption pressed by all cells in the body, whereas the membrane-
worldwide, particularly in the elderly and in patients with bound IL-6R is mainly expressed by hepatocytes, mono-
underlying chronic medical conditions, including pulmo- cytes/macrophages, and some lymphocytes (Taga and
nary diseases and diabetes mellitus. In spite of vaccina- Kishimoto, 1997). Interestingly, IL-6 has been found to
tion, a very recent report showed that 7% of U.S. deaths use an alternative pathway to activate target cells lack-
are still attributable to pneumonia and influenza infec- ing the membrane-bound IL-6 receptor via a naturally
tions (CDC, 2003). Anyone who has experienced a sea- occurring soluble form of the IL-6R (sIL-6R). The sIL-6R
sonal flu might have wondered about the reason behind has been found in various body fluids and is generated
the febrile response of our body. Fever responses occur by two independent mechanisms: limited proteolysis of
in the course of viral and bacterial infections and as a the membrane protein and translation from an alterna-
consequence of tumor growth. Although the fever re- tively spliced mRNA. The sIL-6R together with IL-6 stim-
sponse is evolutionarily conserved, it is the least under- ulates cells that only express gp130, a process that has
stood component of the acute inflammatory response. been named IL-6 trans-signaling (Figure 1A) (Jones and
This may have changed with the work of Sharon Evans Rose-John, 2002). Importantly, it has been shown that
and colleagues, which is published in this issue of Immu- the soluble form of gp130, which is also found in various
nity (Chen et al., 2004). body fluids including plasma, exclusively inhibits IL-6/
The authors show that the adhesion of leukocytes to sIL-6R trans-signaling responses, whereas the stimula-
tissue sections via the L-selectin homing receptor is tion via the membrane-bound IL-6R (classic IL-6 signal-
increased when the temperature is raised from 37C to ing) is unaffected (Figure 1B). This selectivity is due to
the fact that IL-6 alone does not bind to membrane-40C. The activation of L-selectin is dependent on the
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Figure 1. IL-6R trans-Signaling and Its Inhibi-
tion by sgp130 in Lymphocytes
(A) Classical signaling: IL-6 (red) binds to the
membrane-bound IL-6R (blue). Conse-
quently, the IL-6/IL-6R complex binds to
gp130 (green), inducing dimerization and ini-
tiation of signaling. trans-signaling: limited
proteolysis and/or alternative splicing lead to
the generation of sIL-6R, which binds IL-6.
The IL-6/sIL-6R complex can stimulate cells,
which only express gp130 but no IL-6R. In
the absence of sIL-6R, such cells would not
be able to respond to the cytokine IL-6.
(B) IL-6 binds to the membrane-bound IL-6R
but not to sgp130. Therefore, sgp130 does
not block classical signaling. Because the
IL-6/sIL-6R complex binds equally well to
membrane-bound and soluble gp130, a molar
excess of sgp130 completely blocks trans-
signaling responses.
(C) Activation of gp130 in lymphocytes leads
to activation of JAK kinases resulting in
gp130 phosphorylation on tyrosine residues.
This leads to STAT3 recruitment and activa-
tion, which is involved in antiapoptotic re-
sponses via bcl-2 and bcl-xL induction. Acti-
vation of the MEK-1 and ERK1/2 pathway
leads to enhanced interaction of the cyto-
plasmic portion of L-selectin and components
of the cytoskeleton. As a consequence, en-
hanced L-selectin-mediated adhesion to high
endothelial venules (HEV) can be detected.
bound or soluble gp130, whereas the IL-6/sIL-6R com- the authors identified IL-6 as the cytokine involved in
L-selectin activation, demonstrating that neutralizingplex binds with equal affinity to both forms of gp130
(Figure 1B). Therefore, sgp130 is the natural inhibitor of antibodies to IL-6 and IL-6 receptor subunits inhibit ther-
mal activation of L-selectin adhesion. Moreover, the au-IL-6/sIL-6R trans-signaling responses and can be used
as a molecular tool to discriminate between classic sig- thors demonstrated that activation of MEK1 and ERK1-2
kinases in the gp130-signaling pathway lies upstreamnaling and trans-signaling (Jostock et al., 2001).
This remarkable feature of the sgp130 protein was of activation of L-selectin/cytoskeleton interactions and
enhancement of L-selectin avidity/affinity.exploited by Chen et al. in their study on IL-6 signaling in
heat responses. They establish that multiple lymphocyte Intriguingly, recombinant sgp130 blocked tempera-
ture-induced L-selectin adhesion of lymphocytes in vitrosubsets within human peripheral blood are responsive
to thermal stress, resulting in cell adhesion. This process as well as in vivo, indicating that gp130 activation oc-
curred via trans-signaling. This was to be expected,is mediated by L-selectin, because it can be completely
blocked by a neutralizing L-selectin antibody. In contrast because most lymphocytes do not express the mem-
brane-bound IL-6R. Therefore, the authors could con-to lymphocytes, CD14 monocytes do not adhere after
heat stress, which is in line with the failure of these clude that thermal activation of L-selectin adhesion was
mediated by IL-6/sIL-6R trans-signaling (Figure 1C). Thecells to extravasate across lymph node high endothelial
venules. Because conditioned media from thermally ac- proposed scenario of trans-signaling during febrile re-
sponses is described in Figure 5 of the report by Chentivated human peripheral blood leukocytes (PBL) also
induced L-selectin-mediated adhesion, a soluble fac- et al. (2004).
What is so important about trans-signaling? First,tor(s) such as cytokines secreted by these cells was
considered likely to be responsible for the effect. Indeed, there are certainly therapeutic implications for specific
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blockade of IL-6 signaling in vivo. Recent phase I/II clini- noteworthy that in other trans-signaling models like the
peritonitis and rheumatoid arthritis models (Hurst et al.,cal trials have shown that a neutralizing humanized anti-
IL-6R monoclonal antibody (MRA) is beneficial for the 2001; Nowell et al., 2003), no such compensatory mech-
anisms have been found. This might indicate that thetreatment of rheumatoid arthritis, Castleman’s disease,
and potentially Crohn’s disease (Ding and Jones, 2003; febrile response during infections is of particular impor-
tance. This is underlined by the fact that fever has beenIto, 2003). Moreover, using recombinant sgp130 protein,
animal studies have revealed that the progression of conserved for millions of years in very diverse groups
of animals.chronic inflammatory diseases like Crohn’s disease,
peritonitis, and rheumatoid arthritis depends on IL-6/ Chen et al. demonstrate that gp130-mediated Erk1/2
stimulation leads to L-selectin activation and that thesIL-6R trans-signaling (Atreya et al., 2000; Hurst et al.,
2001; Nowell et al., 2003), at least partially due to gp130’s COOH terminal 11 amino acids of L-selectin are neces-
sary for this effect. It is, however, unclear whether phos-capacity to block IL-6-dependent STAT3 and bcl-xL ac-
tivation in T cells and thus to induce T cell apoptosis. phorylation of L-selectin and/or components of the cy-
toskeleton occurs during this process (Figure 1C).Therefore, it can be anticipated that the sgp130 protein
can be used as a more specific therapeutic agent to Therefore, the molecular mechanism of the inside-out
treat these chronic diseases as compared to a neutraliz- signaling from gp130 stimulation to L-selectin activation
ing IL-6R mAb, because it does not interfere with classic will have to be elucidated in more detail. Furthermore,
IL-6 signaling via the membrane-bound IL-6R, which it is so far unclear, whether—as a consequence of Erk1/2
is important, for example, for the hepatic acute phase signaling—the affinity, the subcellular localization, or the
response and for B cell stimulation. On the other hand, oligmerization of L-selectin is affected.
IL-6R trans-signaling responses seem to occur during The described unexpected connection between the
stress responses including chronic inflammatory dis- heat danger signal and IL-6R trans-signaling makes it
eases, liver regeneration, cardiac stress situations, and likely that more examples of this unusual mechanism
as now shown by Chen et al., during febrile responses. will be reported in the future and that the story of IL-6
Therefore, it will be interesting to analyze whether addi- trans-signaling is not completed yet: The heat is on.
tional as yet unidentified stress situations or other in-
flammatory processes also depend on the trans-signal- Stefan Rose-John1 and Markus F. Neurath2
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